Hello, everyone, and how are you today? A sunny day is unfolding here on the Pharmalot corporate campus, where the official mascots are fertilizing the grounds and the short people are hustling off to the schoolhouse. As for us, we are brewing that mandatory cup of stimulation and readying ourselves for another round of meetings, deadlines and R&D. We trust you can relate. To help you along, here are some tidbits. Hope your day goes well and you conquer the world. Stay in touch...
Avastin Labeling Now Warns Of Infertility (Dow Jones)
Biogen MS Drug Trial Reveals No Safety Surprises (Reuters)
Alzheimer's May Be Transmissible: Study (MSNBC)
Celgene Pays $20M To Extend Agios Agreement (Reuters)
AstraZeneca Bloodthinner Gets Initial Reimbursement In Germany (Bloomberg News)
Merck Fine-Tunes Biosimilars Strategy (Xconomy)
Amerisource Bergen To Pay $250M For TheraCom (Outsourcing Pharma)
Bayer Plans To Expand In Japan (Pharma Times)
Why Pozen Wants To Partner Its Heart Drug (MedCity News)
EDITOR'S NOTE: Please check this post for updates throughout the morning